VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹29 Cr | ₹-15 Cr | ₹15 Cr | ₹26 Cr | ₹-0.15 Cr |
What is the latest Net Cash Inflow / Outflow ratio of VENUS REMEDIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹29 Cr |
Mar2023 | ₹-15 Cr |
Mar2022 | ₹15 Cr |
Mar2021 | ₹26 Cr |
Mar2020 | ₹-0.15 Cr |
How is Net Cash Inflow / Outflow of VENUS REMEDIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹29 Cr | Positive | |
Mar2023 | ₹-15 Cr | Negative | |
Mar2022 | ₹15 Cr | -42.89 | |
Mar2021 | ₹26 Cr | Positive | |
Mar2020 | ₹-0.15 Cr | - |
Compare Net Cash Inflow / Outflow of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹637.8 Cr | 6.6% | 4% | 19.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 6.6% |
4% |
19.2% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses